Two recent editorials in the Clinical Journal of the American Society of Nephrology discuss the benefits and drawbacks of telehealth in the context of treating chronic kidney disease now and in the future.
ASN and other groups are urging Congress and the Administration to make a critical investment in the nation’s health care delivery system by maintaining the 3.75% increase to the CF through at least calendar years 2022 and 2023.
ASN Executive Vice President Tod Ibrahim and ASN Regulatory and Quality Officer David White offer insights about federal funding for kidney research, visas for international medical graduates, and the Equality Act.
More than 37,000,000 Americans are affected by kidney diseases, and inequities and disparities have long plagued the care for many of those affected. In a series of key recommendations to the Biden Administration, ASN pledged its support to address the twin public health crises of COVID-19 and systemic racism.